Baseline eosinophil proportion is a useful predictor of immune-related adverse events following immune checkpoint inhibitor treatment for recurrent metastatic head and neck cancer
IrAEs may be associated with higher efficacy of ICIs and longer PFS. The relative eosinophil count may be predictors of irAEs and useful in routine medical practice. Using these biomarkers to predict irAEs will help predict ICI effects and manage irAEs.
Authors
- Takashi Ishino (ORCID: https://orcid.org/0000-0002-0646-0839)
- Sachio Takeno (ORCID: https://orcid.org/0000-0002-9853-2501)
- Nobuyuki Chikuie
- Takayoshi Hattori
- Tsutomu Ueda (ORCID: https://orcid.org/0000-0001-9771-3880)
- Takao Hamamoto (ORCID: https://orcid.org/0000-0001-9728-1264)
- Yuki Sato (ORCID: https://orcid.org/0000-0002-8825-5248)
- Minoru Hattori
- Takayuki Taruya (ORCID: https://orcid.org/0000-0002-5873-9946)
Institutions
- Hiroshima University (JP)
Publication Details
- Journal
- Acta Oto-Laryngologica
- Published
- 2024-09-20
- DOI
- https://doi.org/10.1080/00016489.2024.2390084
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.28